Levofolinic Acid for Injection(Shanghai Huilun Pharma)

注射用左亚叶酸（上海汇伦医药）

Report date: 2026/04/23 17:07:30

Base Information

Drug NameLevofolinic Acid for Injection(Shanghai Huilun Pharma)
Drug Alias NameLevofolinic Acid注射用左亚叶酸（改良型）佐愈
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsChemotherapy induced poisoningLiver NeoplasmsStomach Neoplasms +[4] 
Global Approved IndicationsChemotherapy induced poisoningStomach NeoplasmsColorectal Neoplasms
Approved Indications in ChinaChemotherapy induced poisoningStomach NeoplasmsColorectal Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2021/06/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Huilun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Huilun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy induced poisoningLiver NeoplasmsStomach Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank